| Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829) |
|---|
| 12/11/2003 | WO2003102219A2 Improved pseudotyped retroviruses |
| 12/11/2003 | WO2003102211A2 Method of detecting dna variation in sequence data |
| 12/11/2003 | WO2003102209A2 Alternatively spliced isoforms of human hmg co-a reductase |
| 12/11/2003 | WO2003054212A3 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 12/11/2003 | WO2003052116A3 Methods for detection of a target nucleic acid using multi-subunit probes |
| 12/11/2003 | WO2003040400A3 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies |
| 12/11/2003 | US20030228591 Methods for searching polynucleotide probe targets in databases |
| 12/04/2003 | WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 12/04/2003 | WO2003100076A2 Pna probes, probe sets, method and kits pertaining to the determination of listeria |
| 12/04/2003 | US20030224437 Discriminately identifying nucleic acid sequences of coliform bacteria; high throughput assay |
| 12/04/2003 | CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 12/04/2003 | CA2484010A1 Pna probes, probe sets, methods and kits pertaining to the determination of listeria |
| 12/03/2003 | EP1366360A2 Methods for large scale protein matching |
| 12/02/2003 | CA2046904C Cd4 specific recombinant antibody |
| 11/27/2003 | WO2003097855A2 Small molecule inhibitors of her2 expression |
| 11/27/2003 | WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling |
| 11/27/2003 | WO2003078589A3 Method of identifying genes controlling diferentiation |
| 11/27/2003 | WO2003044214A3 Methods and compositions in checkpoint signaling |
| 11/27/2003 | WO2003040401A3 General screening method for ligand-protein interactions |
| 11/27/2003 | US20030219792 Using recombinase-polymerase amplification to propagate target DNA without the use of thermocycling or thermophilic enzymes |
| 11/27/2003 | US20030219779 Transposon mediated multiplex sequencing |
| 11/27/2003 | CA2485589A1 Small molecule inhibitors of her2 expression |
| 11/26/2003 | EP1364054A2 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 11/26/2003 | EP1364052A2 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 11/13/2003 | WO2003027316A3 Methods of using 33751, a human potassium channel family member |
| 11/13/2003 | WO2002083920A3 Nucleic acid sequences useful in the detection and treatment of various cancers |
| 11/11/2003 | US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma |
| 11/06/2003 | WO2003070964A3 Methods for searching polynucleotide probe targets in databases |
| 11/06/2003 | WO2002059348A3 Methods for determining the genetic affinity of microorganisms and viruses |
| 11/06/2003 | WO2002057489A3 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 11/06/2003 | US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM) |
| 10/30/2003 | WO2003006678A3 System and method for storing mass spectrometry data |
| 10/30/2003 | US20030203374 Assaying cells in a biological sample to distinguish between living and dead cells |
| 10/29/2003 | CN1125877C Hepatitis G. Virus and molecular cloning thereof |
| 10/23/2003 | US20030198959 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 10/16/2003 | WO2003085585A1 A method for gene mapping from genotype and phenotype data |
| 10/16/2003 | WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/16/2003 | WO2002079488A3 Oligonucleotide microchips to detect protein-nucleic acid interactions |
| 10/16/2003 | WO2002077262A3 Method and apparatus for the automated generation of nucleic acid ligands |
| 10/16/2003 | WO2002072868A3 Methods and tools for nucleic acid sequence analysis selection and generation |
| 10/16/2003 | US20030194725 Creating a database of related protein/nucleic acid sequences with annotations of the potential disease associations of the sequences; testing the potential disease associations by means of a biological assay and validating the disease association |
| 10/16/2003 | CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/15/2003 | EP1352063A2 Receptor nucleic acids and polypeptides |
| 10/09/2003 | WO2003082202A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 10/09/2003 | WO2002083929A3 System and method for quantitating transcription factors |
| 10/09/2003 | WO2001071027A3 mRNA AMPLIFICATION |
| 10/09/2003 | CA2479379A1 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 10/02/2003 | US20030186316 Method for identifying optimal binding ligands to a receptor |
| 10/01/2003 | EP0868529B1 Method for detection of ki-ras mutations and kit to perform it |
| 09/30/2003 | US6627226 Dry solid medium for storage and analysis of genetic material |
| 09/25/2003 | WO2003078652A2 Modification of selectivity for sensing for nanostructure device arrays |
| 09/25/2003 | WO2003078589A2 Method of identifying genes controlling diferentiation |
| 09/25/2003 | WO2002061128A3 Method of determining a chemotherapeutic regimen based on ercc1 expression |
| 09/25/2003 | WO2002031203A3 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 09/25/2003 | CA2478986A1 Method of identifying genes controlling differentiation |
| 09/18/2003 | WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 09/18/2003 | US20030176647 Antibodies to OCIF-binding molecules |
| 09/18/2003 | US20030175714 Method for generating amplified RNA |
| 09/18/2003 | US20030175254 Separating population based on density and size of cells via elution then cetrifugation; for secretion of neuroendocrine hormones |
| 09/18/2003 | US20030175161 For electronic detection of chemical and biological materials |
| 09/17/2003 | CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/12/2003 | WO2003074724A2 Polynomial amplification of nucleic acids |
| 09/12/2003 | WO2002090569A3 Family-based association tests for quantitative traits using pooled dna |
| 09/12/2003 | WO2002057414A9 Leukocyte expression profiling |
| 09/04/2003 | WO2003072826A1 Stain-directed molecular analysis for cancer prognosis and diagnosis |
| 09/04/2003 | WO2003072805A2 Recombinase polymerase amplification |
| 09/04/2003 | WO2003072798A2 Method for generating amplified rna |
| 09/04/2003 | WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 09/04/2003 | US20030165934 Methods and compositions in checkpoint signaling |
| 09/04/2003 | US20030165840 Comprises replication of oligonucleotides for detection, diagnosis and treatment of cancer using 5-Fluorouracil-based chemotherapeutic regimen |
| 09/04/2003 | CA2476661A1 Method for generating amplified rna |
| 09/04/2003 | CA2476481A1 Recombinase polymerase amplification |
| 09/04/2003 | CA2457907A1 Stain-directed molecular analysis for cancer prognosis and diagnosis |
| 09/03/2003 | EP1339869A2 Obesity associated biallelic marker maps |
| 09/03/2003 | CN1439646A Method for segregating nucleic acid |
| 08/28/2003 | WO2003070974A2 Mismatch repair detection |
| 08/28/2003 | WO2003070965A2 The eaat2 promoter and uses thereof |
| 08/28/2003 | WO2003070964A2 Methods for searching polynucleotide probe targets in databases |
| 08/28/2003 | US20030162213 Terminal-phosphate-labeled nucleotides and methods of use |
| 08/28/2003 | CA2475188A1 Mismatch repair detection |
| 08/27/2003 | EP1337546A2 Method for detecting hematopoietic stem cells |
| 08/27/2003 | CN1119658C Method for quantitating cholesterol present in low density lipoproteins |
| 08/21/2003 | WO2003060142A9 Compositions and methods for controlled release |
| 08/21/2003 | WO2003004686A3 Fluorescence-based assay for the detection of specific nucleic acids using photon counting |
| 08/21/2003 | WO2002008446A9 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 08/19/2003 | US6607896 Diagnostic test |
| 08/14/2003 | WO2003066882A2 Method and apparatus for validating dna sequences without sequencing |
| 08/14/2003 | WO2003066878A2 Nucleic acid analysis using layered expression scanning |
| 08/14/2003 | US20030152947 Methods for detecting and treating the early onset of aging-related conditions |
| 08/13/2003 | EP1334113A2 Leukocyte expression profiling |
| 08/07/2003 | US20030148345 Methods for evaluating drug-resistance gene expression in the cancer patient |
| 08/07/2003 | US20030148343 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
| 08/07/2003 | US20030148310 Incubating; signal generated after dissociation; increased intensity; does not require cleavage |
| 08/06/2003 | CN1435028A System and method for communicating data over multiple networks |
| 08/06/2003 | CN1434832A DNA for encoding the RGI polypeptide |
| 08/05/2003 | US6602670 Treating tumors; obtain tissue sample, isolate nucleotide sequences, amplify nucleotide sequences, monitor nucleotide sequence concentration of marker gene, compare to control |
| 07/31/2003 | WO2003062450A2 Probe correction for gene expression level detection |
| 07/31/2003 | WO2002024909A3 Receptor nucleic acids and polypeptides |